• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性上叶肺癌患者总生存预测列线图的开发:一项基于监测、流行病学和最终结果(SEER)数据库人群的分析

Development of a nomogram for overall survival prediction in primary upper lobe lung cancer patients: A SEER population-based analysis.

作者信息

Yu Wenze, Long Lu, Hou Qizhuo, Yi Bin

机构信息

Department of Clinical Laboratory, Xiangya Hospital, Central South University, Changsha, Hunan, China.

出版信息

PLoS One. 2025 Apr 29;20(4):e0321955. doi: 10.1371/journal.pone.0321955. eCollection 2025.

DOI:10.1371/journal.pone.0321955
PMID:40299864
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12040116/
Abstract

BACKGROUND

The upper lobe is the most common site of primary lung cancer, however, very few reports focus on its prognosis. This study aims to identify prognostic factors of lung cancer in the upper lobe, as well as to establish an effective nomogram for individualized overall survival (OS) prediction.

METHODS

Patients diagnosed with lung cancer were collected from the Surveillance, Epidemiology, and End Results Program (SEER) database for the period of 2010-2017,as recorder in the 2021 SEER database release. The demographic characteristics and OS differed in the primary sites of the upper, middle and lower lobes were drawn. The primary upper lobe lung cancer patients were further stratified by the risk indicators including Mets at DX-bone, stage, histology, grade and sex; and their OS differences in stratification were compared by the Kaplan-Meier method and the Log-Rank test. The univariate and the multivariate Cox regression were employed to determine the independent prognostic factors for the primary upper lobe lung cancer and to build a nomogram model for its OS prediction.

RESULTS

Depending on the different primary sites of lung cancer occurrence, all the collected patients were divided into three groups of the upper lobe (30295 individuals), the middle lobe (2801 individuals) and the lower lobe (16757 individuals), where the upper lobe group gained our attention with the largest population and an overwhelmingly low OS compared to the middle lobe group (P <0.0001). With the results of the univariate and multivariate Cox regression model analyses, age, sex, grade, histology type, stage, regional lymph nodes removed, bone metastasis and liver metastasis were selected as the prognostic factors and a prediction nomogram model was built. The calibration curves showed no significant bias from the reference line and the concordance index between the survival nomogram prediction and the actual outcome for 2-year and 3-year OS was 0.761 (95% CI, 0.757-0.765). The time-dependent receiver operating characteristic curves showed that the areas under curve for 2-year and 3-year OS were 0.840 and 0.836, respectively.

CONCLUSION

A novel nomogram was established which achieved good performance in predicting the probability of OS in the primary upper lobe lung cancer, indicating its potential value in individualized prediction of the clinical outcome in these patients.

摘要

背景

上叶是原发性肺癌最常见的部位,然而,很少有报告关注其预后情况。本研究旨在确定上叶肺癌的预后因素,并建立一个有效的列线图用于个体化总生存期(OS)预测。

方法

从监测、流行病学和最终结果计划(SEER)数据库中收集2010 - 2017年诊断为肺癌的患者信息,这些信息记录在2021年SEER数据库版本中。绘制了上叶、中叶和下叶不同原发部位患者的人口统计学特征和总生存期差异。将原发性上叶肺癌患者根据诊断时骨转移(Mets at DX - bone)、分期、组织学类型、分级和性别等风险指标进一步分层;采用Kaplan - Meier法和对数秩检验比较各分层中患者的总生存期差异。采用单因素和多因素Cox回归确定原发性上叶肺癌的独立预后因素,并构建用于总生存期预测的列线图模型。

结果

根据肺癌发生的不同原发部位,将所有收集的患者分为上叶组(30295例)、中叶组(2801例)和下叶组(16757例),其中上叶组人数最多且与中叶组相比总生存期极低,引起了我们的关注(P <0.0001)。通过单因素和多因素Cox回归模型分析结果,选择年龄、性别、分级、组织学类型、分期、切除的区域淋巴结、骨转移和肝转移作为预后因素,并构建了预测列线图模型。校准曲线显示与参考线无显著偏差,生存列线图预测与2年和3年总生存期实际结果之间的一致性指数为0.761(95%CI,0.757 - 0.765)。时间依赖性受试者工作特征曲线显示,2年和3年总生存期的曲线下面积分别为0.840和0.836。

结论

建立了一种新型列线图,在预测原发性上叶肺癌总生存期概率方面表现良好,表明其在这些患者临床结局个体化预测中的潜在价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d416/12040116/c48b81611b76/pone.0321955.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d416/12040116/ccb4430086a6/pone.0321955.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d416/12040116/caa118b422c9/pone.0321955.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d416/12040116/133a0a4447e3/pone.0321955.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d416/12040116/db13f6d5283e/pone.0321955.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d416/12040116/c50466caf7a2/pone.0321955.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d416/12040116/b3913ff1d155/pone.0321955.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d416/12040116/c48b81611b76/pone.0321955.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d416/12040116/ccb4430086a6/pone.0321955.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d416/12040116/caa118b422c9/pone.0321955.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d416/12040116/133a0a4447e3/pone.0321955.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d416/12040116/db13f6d5283e/pone.0321955.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d416/12040116/c50466caf7a2/pone.0321955.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d416/12040116/b3913ff1d155/pone.0321955.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d416/12040116/c48b81611b76/pone.0321955.g007.jpg

相似文献

1
Development of a nomogram for overall survival prediction in primary upper lobe lung cancer patients: A SEER population-based analysis.原发性上叶肺癌患者总生存预测列线图的开发:一项基于监测、流行病学和最终结果(SEER)数据库人群的分析
PLoS One. 2025 Apr 29;20(4):e0321955. doi: 10.1371/journal.pone.0321955. eCollection 2025.
2
A nomogram to predict postoperative overall and cancer specific survival in patients with primary parotid squamous cell carcinoma: a population based study.预测原发性腮腺鳞状细胞癌患者术后总体生存率和癌症特异性生存率的列线图:一项基于人群的研究。
Sci Rep. 2025 Feb 25;15(1):6774. doi: 10.1038/s41598-025-90480-8.
3
A new nomogram and risk classification system for predicting survival in small cell lung cancer patients diagnosed with brain metastasis: a large population-based study.一个用于预测小细胞肺癌脑转移患者生存的新列线图和风险分类系统:一项大型基于人群的研究。
BMC Cancer. 2021 May 29;21(1):640. doi: 10.1186/s12885-021-08384-5.
4
Nomogram predicting overall survival of rectal squamous cell carcinomas patients based on the SEER database: A population-based STROBE cohort study.基于监测、流行病学和最终结果(SEER)数据库预测直肠鳞状细胞癌患者总生存期的列线图:一项基于人群的加强观察性研究报告(STROBE)队列研究
Medicine (Baltimore). 2019 Nov;98(46):e17916. doi: 10.1097/MD.0000000000017916.
5
Development and Validation of an Individualized Nomogram for Predicting Overall Survival in Patients With Typical Lung Carcinoid Tumors.典型肺类癌肿瘤患者总生存个体化列线图的建立与验证。
Am J Clin Oncol. 2020 Sep;43(9):607-614. doi: 10.1097/COC.0000000000000715.
6
Establishment of prognostic nomogram for high-grade parotid gland mucoepidermoid carcinoma based on the SEER database.基于监测、流行病学和最终结果(SEER)数据库建立高级别腮腺黏液表皮样癌的预后列线图
Ear Nose Throat J. 2025 Feb;104(2):NP75-NP84. doi: 10.1177/01455613221089994. Epub 2022 Apr 13.
7
Prognostic Nomogram for Overall Survival in Small Cell Lung Cancer Patients Treated with Chemotherapy: A SEER-Based Retrospective Cohort Study.化疗治疗小细胞肺癌患者总生存预后列线图:基于 SEER 的回顾性队列研究。
Adv Ther. 2022 Jan;39(1):346-359. doi: 10.1007/s12325-021-01974-6. Epub 2021 Nov 3.
8
Development and validation of prognostic nomograms for early-onset colon cancer in different tumor locations: a population-based study.不同肿瘤部位早发性结肠癌预后列线图的建立与验证:基于人群的研究。
BMC Gastroenterol. 2023 Oct 21;23(1):362. doi: 10.1186/s12876-023-02991-1.
9
Prediction of all-cause death and specific causes of death in patients with gastric cancer with liver metastasis: a Surveillance, Epidemiology, and End Results-based study.基于监测、流行病学和最终结果的研究:预测患有肝转移胃癌患者的全因死亡和特定死因。
J Gastrointest Surg. 2024 Jun;28(6):880-888. doi: 10.1016/j.gassur.2024.03.019. Epub 2024 Mar 18.
10
Nomograms predicting the overall survival and cancer-specific survival of patients with stage IIIC1 cervical cancer.列线图预测 IIIC1 期宫颈癌患者的总生存和癌症特异性生存。
BMC Cancer. 2021 Apr 23;21(1):450. doi: 10.1186/s12885-021-08209-5.

本文引用的文献

1
Uncertainty of risk estimates from clinical prediction models: rationale, challenges, and approaches.临床预测模型风险估计的不确定性:基本原理、挑战及应对方法。
BMJ. 2025 Feb 13;388:e080749. doi: 10.1136/bmj-2024-080749.
2
Cancer incidence and mortality in China, 2022.2022年中国癌症发病率与死亡率
J Natl Cancer Cent. 2024 Feb 2;4(1):47-53. doi: 10.1016/j.jncc.2024.01.006. eCollection 2024 Mar.
3
Non-Small Cell Lung Cancer, Version 4.2024, NCCN Clinical Practice Guidelines in Oncology.非小细胞肺癌临床实践指南(第 4.2024 版),NCCN 肿瘤学临床实践指南
J Natl Compr Canc Netw. 2024 May;22(4):249-274. doi: 10.6004/jnccn.2204.0023.
4
The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groups in the Forthcoming (Ninth) Edition of the TNM Classification for Lung Cancer.国际肺癌研究协会肺癌分期项目:对即将发布的(第九版)肺癌 TNM 分类中 TNM 分期组的修订建议。
J Thorac Oncol. 2024 Jul;19(7):1007-1027. doi: 10.1016/j.jtho.2024.02.011. Epub 2024 Mar 4.
5
Distribution and characteristics of malignant tumours by lung lobe.肺叶恶性肿瘤的分布与特征。
BMC Pulm Med. 2024 Mar 4;24(1):106. doi: 10.1186/s12890-024-02918-w.
6
Evaluation of clinical prediction models (part 1): from development to external validation.临床预测模型的评估(第 1 部分):从建立到外部验证。
BMJ. 2024 Jan 8;384:e074819. doi: 10.1136/bmj-2023-074819.
7
Lung Cancer in Women: The Past, Present, and Future.女性肺癌:过去、现在与未来
Clin Lung Cancer. 2024 Jan;25(1):1-8. doi: 10.1016/j.cllc.2023.10.007. Epub 2023 Oct 20.
8
Estrogen Receptor and Immune Checkpoint Inhibitors: New Partners in Lung Cancer?雌激素受体与免疫检查点抑制剂:肺癌治疗的新伙伴?
Clin Cancer Res. 2023 Oct 2;29(19):3832-3834. doi: 10.1158/1078-0432.CCR-23-1736.
9
Primary tumor location in lung cancer: the evaluation and administration.肺癌的原发肿瘤部位:评估与管理。
Chin Med J (Engl). 2021 Nov 15;135(2):127-136. doi: 10.1097/CM9.0000000000001802.
10
Toward personalized treatment approaches for non-small-cell lung cancer.针对非小细胞肺癌的个体化治疗方法。
Nat Med. 2021 Aug;27(8):1345-1356. doi: 10.1038/s41591-021-01450-2. Epub 2021 Aug 12.